Experience

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the SEC-registered offering of 4,400,000 shares of common stock of Sun Hydraulics…

Davis Polk advised the underwriters in connection with the offering by the Province of Ontario of CAD1 billion aggregate principal amount of its 2.65% bonds due February 5, 2025. The net…

Davis Polk advised Dufry AG (Dufry) and its subsidiary, Hudson Ltd., in connection with the $748.9 million initial public offering of 39,417,765 Class A common shares of Hudson Ltd. The…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,269,230 shares…

Davis Polk advised Ultra Clean Holdings, Inc. on its SEC-registered follow-on public offering of 4,761,905 shares of common stock for an aggregate price to the public of approximately $100…

Davis Polk advised Natura Cosméticos S.A. in connection with its $750 million offering of 5.375% senior notes due 2023, which were issued pursuant to Rule 144A and Regulation S under the…

Davis Polk is advising the joint lead arrangers, joint bookrunners and the administrative agent in connection with a $2.5 billion unsecured bridge facility to be…

Davis Polk advised Grupo Financiero Santander México, S.A.B. de C.V. (“Grupo Financiero Santander México”) and Banco Santander (México), S.A., Institución de Banca Múltiple, Grupo…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Varian Medical Systems, Inc. in connection with its approximately A$1.6 billion acquisition of Sirtex Medical…

Davis Polk advised Auris Medical Holding AG on its registered direct offering of 12,499,999 of its common shares and concurrent private placement of warrants to purchase up to 7,499,999 of…